UPDATE 3-Biogen scraps Alzheimer drug trials, wiping $17 billion off its market value
March 21, 2019 at 10:15 AM EDT
* Analysts question Biogen's growth prospects (Adds context, details, background)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.